Skip to main content
An official website of the United States government
Español
Email

Cancer Currents: An NCI Cancer Research Blog

A blog featuring news and research updates from the National Cancer Institute.

An illustrated banner to represent NCI's Cancer Currents research news blog. The design features interconnected scenes: a patient receiving care, a researcher in a lab, a tumor model, a laptop and mobile device displaying research articles, fitness activity, a clinical setting, and a researcher giving a scientific presentation. The background showcases rolling hills and abstract buildings.
  • Laboratory fertilization of eggs in IVF treatment
    • By NCI Staff

    Fertility preservation for young women with breast cancer doesn’t increase their risk of dying in the ensuing decades, a new study affirmed. Experts said the findings support routinely offering fertility preservation to patients who want it.

  • A diagram of the process of infection to the detection of antibodies to the coronavirus.
    • By Norman E. Sharpless, M.D.

    In a study using data from more than 3 million people, NCI researchers have found that people who have antibodies to SARS-CoV-2, the virus that causes COVID-19, appear to have some degree of protection against being reinfected with the virus.

  • A picture of an older woman sitting on a couch, with one hand on her temple.
    • By NCI Staff

    For adults with CML who are in a sustained deep molecular remission, stopping treatment with a tyrosine kinase inhibitor is safe and improves their quality of life, a study shows. But researchers cautioned that these patients must be closely monitored.

  • MHC Cancer Cell Interacting with a T-Cell
    • By NCI Staff

    Cholesterol-lowering drugs known as PCSK9 inhibitors may improve the effectiveness of cancer immune checkpoint inhibitors, according to studies in mice. The drugs appear to improve the immunotherapy drugs’ ability to find tumors and slow their growth.

  • An illustration of the tumor microenvironment, highlighting cancer cells and different types of immune cells.
    • By NCI Staff

    Researchers have developed a nanoparticle that trains immune cells to attack cancer. According to the NCI-funded study, the nanoparticle slowed the growth of melanoma in mice and was more effective when combined with an immune checkpoint inhibitor.

  • An image of a blood being collected into a tube from a male patient.
    • By NCI Staff

    FDA has expanded the approved uses of the FoundationOne Liquid CDx blood test, known as a liquid biopsy, that can help doctors pick specific treatments for some people with cancer. When used in this way, the test is known as a companion diagnostic.

  • An image of an MRI showing a metastatic tumor in a patient's spine.
    • By NCI Staff

    For some patients with painful spinal metastases from advanced cancer, a type of precise, high-dose radiation therapy—called stereotactic body radiation therapy (SBRT)—may be a highly effective way to relieve that pain, clinical trial results show.

  • Persistent Poverty Counties, 2015 Edition Map
    • By Elia Ben-Ari

    People who live in counties in the United States with persistent poverty are more likely to die from cancer than people in other counties, a new study shows, highlighting the influence of social and structural factors on health.

  • A Hispanic man sitting in a waiting room looking at his smartphone.
    • By NCI Staff

    People with cancer find significant value in having access to electronic clinical notes from their doctor visits, a new study shows. Expanded access to these “open notes” will soon be required under the 21st Century Cures Act.

  • Fundoscopic exam revealing an intraocular retinoblastoma before treatment with intra-arterial chemotherapy
    • By NCI Staff

    For children with the eye cancer retinoblastoma, researchers are studying a CAR T-cell therapy in which the engineered immune cells are packaged in a biodegradable material called a hydrogel and then injected directly into tumors.

< Older Posts Newer Posts >
Email